Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn:
“An AI co-scientist to accelerate biomedical research.
The AI agent Biomni performs research tasks across diverse biomedical fields; with further training and optimization, it could be a powerful research partner for scientists.”
Title: An AI co-scientist to accelerate biomedical research
Authors: Karen O’Leary
Other articles featuring Vivek Subbiah on OncoDaily.